BPC-157 Side Effects: What's Known and What Isn't

BPC-157 is often described online as a peptide with "no side effects." That claim says more about the evidence than about the peptide. BPC-157 has been studied mostly in rats and mice, and only a handful of very small human reports have been published. With so little human data, nobody can say how common side effects are, how serious they can be, or what happens with long-term use.

This guide sets out what is actually known: what the small human studies reported, what people commonly describe online, the theoretical risks researchers have raised, the product-quality problem, and where BPC-157 stands legally and in anti-doping rules in 2026. It does not cover dosing, because no safe or effective dose has been established in humans.

BPC-157 (Body Protection Compound 157) is a synthetic chain of 15 amino acids based on a sequence from a protein found in human gastric juice. In animal studies it has been reported to speed healing of tendons, ligaments, muscle and the gut lining, largely by influencing blood vessel growth and the nitric oxide system. That animal research is why lifters became interested in it for injuries. We cover the evidence for specific uses in BPC-157 for tendon recovery and BPC-157 for shoulder pain.

The key point for safety is that almost all of this research was done in animals, much of it by a single research group. Results in rodents often fail to hold up in people, and the same applies to safety: an absence of harm in rats is not evidence of safety in humans.

Only a few human reports have been published, and each is small:

These reports are useful as early signals, but they cannot establish safety. None was a randomized controlled trial, the numbers were tiny, follow-up was short, and all came from private clinical practice. A 2025 narrative review of BPC-157 for musculoskeletal healing concluded that human evidence remains very limited and that well-designed trials are needed before its benefits or risks can be judged.

Much of what is written about BPC-157 side effects comes from forums, social media and clinics that sell it. These reports cannot tell you how often a side effect happens or whether BPC-157 caused it, but the same complaints come up repeatedly:

Some of these may come from the injection itself, from contaminants in the product, or from other substances taken at the same time. Without controlled studies there is no way to separate them.

Seek medical care promptly for spreading redness, warmth, swelling or pus at an injection site, fever, a rash or hives, swelling of the face or throat, trouble breathing, chest pain, or fainting. These can signal infection or a serious allergic reaction.

Beyond what has been reported, researchers and regulators have pointed to several risks that have not been studied properly in people.

One of the ways BPC-157 is thought to help healing is by promoting angiogenesis, the growth of new blood vessels. Tumors also depend on new blood vessels to grow. A 2025 literature review noted that, for this reason, BPC-157 could in theory encourage the growth of an existing, undetected cancer. There is no human evidence that it causes cancer, but there is also no long-term human data to rule this out. This is one reason doctors are cautious about using it in anyone with a history of cancer.

No study has followed people taking BPC-157 for months or years. Effects on blood pressure, the nitric oxide system, the liver, the kidneys or hormone levels with repeated use have not been studied in humans. Effects during pregnancy and breastfeeding are completely unknown.

When FDA reviewed BPC-157 for compounding in 2023, it said it had very limited safety information and flagged possible immune reactions and peptide-related impurities as concerns. Injected peptides can trigger immune responses, and impurities left over from manufacturing can add risk.

Interactions with prescription medicines have not been studied. Because animal studies suggest effects on blood vessels and nitric oxide, people taking blood pressure medicines, blood thinners or medicines for erectile dysfunction should be especially careful and talk to a doctor.

For many people the biggest practical risk is not the peptide itself but what is actually in the vial. BPC-157 sold online is usually labeled "for research use only" or "not for human consumption." These products are not made under pharmaceutical manufacturing standards and are not checked by any regulator. That leaves several risks:

The U.S. Anti-Doping Agency has specifically warned that BPC-157 is an experimental substance and that athletes buying it face both health risks and the risk of an anti-doping violation.

BPC-157 is not an FDA-approved drug for any condition, and it cannot legally be sold as a dietary supplement. Its compounding status has changed several times:

Even if FDA eventually allows compounding, that would not make BPC-157 an approved drug, and it would not mean its safety has been established. Rules can change quickly in this area, so check current FDA guidance and your state's rules.

For athletes, the situation is clearer: BPC-157 has been on the WADA Prohibited List since 2022 under section S0, non-approved substances. It is banned at all times, in and out of competition.

Given how little is known, the following groups have particular reason to avoid it unless a doctor directs otherwise:

If you are considering BPC-157 for a tendon or joint problem, a sports medicine doctor or physical therapist is the best first step. Progressive loading programs have good evidence for many tendon problems, and a proper diagnosis may change what treatment makes sense. If you are weighing recovery peptides, our comparison of BPC-157 vs TB-500 and our guides to the Wolverine stack and TB-500 for muscle recovery cover what the evidence does and does not show.

This article is for information only. It is not medical advice and does not recommend using BPC-157. Talk to a doctor before using any unapproved substance.